{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:58Z","timestamp":1792425538602,"version":"4.5.0"},"publisher-location":"Cham","reference-count":57,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030332488","type":"print"},{"value":"9783030332495","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/5584_2019_408","type":"book-chapter","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T13:03:14Z","timestamp":1563454994000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pertussis: Identification, Prevention and Control"],"prefix":"10.1007","author":[{"given":"Paola","family":"Stefanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"408_CR1","doi-asserted-by":"crossref","unstructured":"Altunaiji S, Kukuruzovic R, Curtis N, Massie J (2007) Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev (3):CD004404","DOI":"10.1002\/14651858.CD004404.pub3"},{"key":"408_CR2","volume-title":"Communicable Disease Network of Australia. CDNA national guidelines for public health units: pertussis [website]","author":"Australian Government Department of Health","year":"2015","unstructured":"Australian Government Department of Health (2015) Communicable Disease Network of Australia. CDNA national guidelines for public health units: pertussis [website]. Australian Government Department of Health, Canberra. http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/content\/cdna-song-pertussis.htm"},{"key":"408_CR3","doi-asserted-by":"crossref","unstructured":"Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim DF, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, Auranen K, He Q (2018) Surveillance of circulating Bordetella pertussis strains in Europe during 1998 to 2015. J Clin Microbiol 56(5). pii: e01998-17","DOI":"10.1128\/JCM.01998-17"},{"key":"408_CR4","doi-asserted-by":"publisher","unstructured":"Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, Stefanelli P, van Gent M, Berbers G, Vestrheim D, Greve-Isdahl M, Wehlin L, Ljungman M, Fry NK, Markey K, He Q (2019) Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill 24(7). https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.7.1700832","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1128\/JCM.41.3.1167-1172.2003","volume":"41","author":"JM Bartkus","year":"2003","unstructured":"Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK et al (2003) Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol 41:1167\u20131172","journal-title":"J Clin Microbiol"},{"key":"408_CR6","first-page":"48","volume":"20","author":"J Bordet","year":"1906","unstructured":"Bordet J, Gengou O (1906) Le microbe de la coqueluche. Ann Inst Pasteur (Paris) 20:48\u201368","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/gb-2006-7-9-r81","volume":"7","author":"MM Brinig","year":"2006","unstructured":"Brinig MM, Register KB, Ackermann MR, Relman DA (2006) Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol 7:R81","journal-title":"Genome Biol"},{"issue":"12","key":"408_CR8","doi-asserted-by":"publisher","first-page":"pii: a029454","DOI":"10.1101\/cshperspect.a029454","volume":"9","author":"N Burdin","year":"2017","unstructured":"Burdin N, Handy LK, Plotkin SA (2017) What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines. Cold Spring Harb Perspect Biol 9(12):pii: a029454","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"10","key":"408_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1099\/jmm.0.000829","volume":"67","author":"H Campbell","year":"2018","unstructured":"Campbell H, Gupta S, Dolan GP, Kapadia SJ, Kumar Singh A, Andrews N, Amirthalingam G (2018) Review of vaccination in pregnancy to prevent pertussis in early infancy. J Med Microbiol 67(10):1426\u20131456","journal-title":"J Med Microbiol"},{"key":"408_CR10","first-page":"807","volume":"43","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","unstructured":"Centers for Disease Control and Prevention (CDC) (1994) Erythromycin-resistant Bordetella pertussis\u2014Yuma County, Arizona, May\u2013October 1994. MMWR Morb Mortal Wkly Rep 43:807\u2013810","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"408_CR11","first-page":"1424","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC) (2011) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 60:1424\u20131426","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"408_CR12","first-page":"131","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC) (2013) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 62:131\u2013135","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/infdis\/174.Supplement_3.S259","volume":"174","author":"JD Cherry","year":"1996","unstructured":"Cherry JD (1996) Historical review of pertussis and the classical vaccine. J Infect Dis 174:259\u2013263","journal-title":"J Infect Dis"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1542\/peds.81.6.933","volume":"81","author":"JD Cherry","year":"1988","unstructured":"Cherry JD, Brunell PA, Golden GS, Karzon DT (1988) Report of the task force on pertussis and pertussis immunization\u20141988. Pediatrics 81:939\u2013984","journal-title":"Pediatrics"},{"key":"408_CR15","unstructured":"Commission Implementing Decision (EU) 2018\/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions"},{"key":"408_CR16","first-page":"580","volume":"96","author":"JA Englund","year":"1995","unstructured":"Englund JA, Anderson EL, Reed GF, Decker MD, Edwards KM et al (1995) The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 96:580\u2013584","journal-title":"Pediatrics"},{"key":"408_CR17","unstructured":"European Center for Disease Prevention and Control (2012a) Guidance and protocol for the use of realtime PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/Guidance-protocol-PCR-laboratory-diagnosis-bordatella-pertussis-parapertussis.pdf"},{"key":"408_CR18","unstructured":"European Center for Disease Prevention and Control (2012b) Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/bordetella-pertussis-guidance-protocol-serological-diagnosis.pdf"},{"issue":"11","key":"408_CR19","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1080\/21645515.2015.1070984","volume":"11","author":"AN Faucette","year":"2015","unstructured":"Faucette AN, Pawlitz MD, Pei B, Yao F, Chen K (2015) Immunization of pregnant women: future of early infant protection. Hum Vaccin Immunother 11(11):2549\u20132555","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"408_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diagmicrobio.2017.11.006","volume":"90","author":"G Fedele","year":"2018","unstructured":"Fedele G, Leone P, Bellino S, Schiavoni I, Pavia C, Lazzarotto T, Stefanelli P (2018) Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies. Diagn Microbiol Infect Dis 90(3):157\u2013162","journal-title":"Diagn Microbiol Infect Dis"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1099\/jmm.0.009878-0","volume":"58","author":"NK Fry","year":"2009","unstructured":"Fry NK, Duncan J, Wagner K, Tzivra O, Doshi N, Litt DJ, Crowcroft N, Miller E, George RC, Harrison TG (2009) Role of PCR in the diagnosis of pertussis infection in infants: 5 years\u2019 experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58:1023\u20131029","journal-title":"J Med Microbiol"},{"issue":"5","key":"408_CR22","doi-asserted-by":"publisher","first-page":"F456","DOI":"10.1136\/archdischild-2016-312341","volume":"102","author":"D Gkentzi","year":"2017","unstructured":"Gkentzi D, Katsakiori P, Marangos M, Hsia Y, Amirthalingam G, Heath PT, Ladhani S (2017) Maternal vaccination against pertussis: a systematic review of the recent literature. Arch Dis Child Fetal Neonatal Ed 102(5):F456\u2013F463","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3201\/eid1806.120091","volume":"18","author":"S Guillot","year":"2012","unstructured":"Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N (2012) Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis 18:966\u2013968","journal-title":"Emerg Infect Dis"},{"key":"408_CR24","volume-title":"Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis\/Bordetella parapertussis, update 2014","author":"S Guillot","year":"2014","unstructured":"Guillot S, Guiso N, Riffelmann M, Wirsing Von K\u00f6nig CH (2014) Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis\/Bordetella parapertussis, update 2014. World Health Organization, Geneva"},{"issue":"9","key":"408_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1586\/14760584.2014.942221","volume":"13","author":"N Guiso","year":"2014","unstructured":"Guiso N, Hegerle N (2014) Other Bordetellas, lessons for and from pertussis vaccines. Expert Rev Vaccines 13(9):1125\u20131133","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"408_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/cid\/ciy244","volume":"67","author":"SA Halperin","year":"2018","unstructured":"Halperin SA, Langley JM, Ye L, MacKinnon-Cameron D, Elsherif M, Allen VM, Smith B, Halperin BA, McNeil SA, Vanderkooi OG, Dwinnell S, Wilson RD, Tapiero B, Boucher M, Le Saux N, Gruslin A, Vaudry W, Chandra S, Dobson S, Money D (2018) A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis 67(7):1063\u20131071","journal-title":"Clin Infect Dis"},{"key":"408_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12879-015-0777-3","volume":"15","author":"M Hara","year":"2015","unstructured":"Hara M, Fukuoka M, Tashiro K et al (2015) Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan. BMC Infect Dis 15:45","journal-title":"BMC Infect Dis"},{"issue":"9","key":"408_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1586\/14760584.2014.932254","volume":"13","author":"N Hegerle","year":"2014","unstructured":"Hegerle N, Guiso N (2014) Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 13(9):1135\u20131146","journal-title":"Expert Rev Vaccines"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00083-15","volume":"29","author":"PE Kilgore","year":"2016","unstructured":"Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ (2016) Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev 29:449\u2013486","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"408_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/infdis\/jiu322","volume":"210","author":"R Koepke","year":"2014","unstructured":"Koepke R, Eickhoff JC, Ayele RA et al (2014) Estimating the effectiveness of tetanus, diphtheria, acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis 210(6):942\u2013953","journal-title":"J Infect Dis"},{"issue":"4","key":"408_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3201\/eid1704.101480","volume":"17","author":"A Le Coustumier","year":"2011","unstructured":"Le Coustumier A, Njamkepo E, Cattoir V, Guillot S (2011) Guiso N. Bordetella petrii infection with long-lasting persistence in human. Emerg Infect Dis 17(4):612\u2013618","journal-title":"Emerg Infect Dis"},{"key":"408_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195979","volume":"13","author":"AD Lee","year":"2018","unstructured":"Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, Lucia Tondella M, Martin SW (2018) Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT). PLoS One 13:e0195979","journal-title":"PLoS One"},{"issue":"4","key":"408_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/14760584.2018.1445530","volume":"17","author":"F Martin\u00f3n-Torres","year":"2018","unstructured":"Martin\u00f3n-Torres F, Heininger U, Thomson A, Wirsing von K\u00f6nig CH (2018) Controlling pertussis: how can we do it? A focus on immunization. Expert Rev Vaccines 17(4):289\u2013297","journal-title":"Expert Rev Vaccines"},{"key":"408_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","volume":"18","author":"S Mattoo","year":"2005","unstructured":"Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326\u2013382","journal-title":"Clin Microbiol Rev"},{"key":"408_CR35","volume-title":"Pertussis: NICD recommendations for diagnosis, management and public health response","author":"National Institute for Communicable Diseases","year":"2017","unstructured":"National Institute for Communicable Diseases (2017) Pertussis: NICD recommendations for diagnosis, management and public health response. National Institute for Communicable Diseases, Johannesburg. http:\/\/www.nicd.ac.za\/wp-content\/uploads\/2017\/03\/Guidelines_pertussis_v1_20-December-2017_Final.pdf"},{"key":"408_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","volume":"5","author":"S Niewiesk","year":"2014","unstructured":"Niewiesk S (2014) Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 5:446","journal-title":"Front Immunol"},{"issue":"3","key":"408_CR37","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/INF.0000000000001418","volume":"36","author":"E1 Pandolfi","year":"2017","unstructured":"Pandolfi E1, Gesualdo F, Carloni E, Villani A, Midulla F, Carsetti R, Stefanelli P, Fedele G, Tozzi AE (2017) Pertussis study group. Does breastfeeding protect young infants from pertussis? Case-control study and immunologic evaluation. Pediatr Infect Dis J 36(3):e48\u2013e53","journal-title":"Pediatr Infect Dis J"},{"key":"408_CR38","unstructured":"Piano Nazionale Prevenzione Vaccinale, PNPV 2017\u20132019. http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf"},{"issue":"8","key":"408_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1586\/14787210.2015.1056161","volume":"13","author":"LF Pittet","year":"2015","unstructured":"Pittet LF, Posfay-Barbe KM (2015) Bordetella holmesii infection: current knowledge and a vision for future research. Expert Rev Anti-Infect Ther 13(8):965\u2013971","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","volume":"54","author":"SA Plotkin","year":"2012","unstructured":"Plotkin SA, Gilbert PB (2012) Nomenclature for immune correlates of protection after vaccination. Clin Infect Dis 54:1615\u20131617","journal-title":"Clin Infect Dis"},{"issue":"Pt 2","key":"408_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1099\/13500872-140-2-255","volume":"140","author":"JF Porter","year":"1994","unstructured":"Porter JF, Connor K, Donachie W (1994) Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology 140(Pt 2):255\u2013261","journal-title":"Microbiology"},{"key":"408_CR42","volume-title":"Guidelines for the public health management of pertussis in England","author":"Public Health England","year":"2018","unstructured":"Public Health England (2018) Guidelines for the public health management of pertussis in England. Public Health England, London. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/576061\/Guidelines_for_the_Public_Health_Management_of_Pertussis_in_England.pdf"},{"issue":"1","key":"408_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.13275","volume":"197","author":"T. F. Rice","year":"2019","unstructured":"Rice TF, Diavatopoulos DA, Smits GP, van Gageldonk PGM, Berbers GAM, van der Klis FR, Vamvakas G, Donaldson B, Bouqueau M, Holder B, Kampmann B (2019) Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy \u2013 a prospective, observational cohort study from the United Kingdom. Clin Exp Immunol. https:\/\/doi.org\/10.1111\/cei.13275","journal-title":"Clinical & Experimental Immunology"},{"issue":"46","key":"408_CR44","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1016\/j.vaccine.2015.09.064","volume":"33","author":"A Safarchi","year":"2015","unstructured":"Safarchi A, Octavia S, Luu LD, Tay CY, Sintchenko V, Wood N, Marshall H, McIntyre P, Lan R (2015) Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine 33(46):6277\u20136281","journal-title":"Vaccine"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","volume":"36","author":"N Saul","year":"2018","unstructured":"Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S (2018) Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study. Vaccine 36:1887\u20131892","journal-title":"Vaccine"},{"issue":"4","key":"408_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/600885","volume":"49","author":"P Seng","year":"2009","unstructured":"Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE et al (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49(4):543\u2013551","journal-title":"Clin Infect Dis"},{"issue":"33","key":"408_CR47","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1016\/j.vaccine.2018.06.044","volume":"36","author":"S Sheikh","year":"2018","unstructured":"Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N (2018) A report on the status of vaccination in Europe. Vaccine 36(33):4979\u20134992","journal-title":"Vaccine"},{"key":"408_CR48","doi-asserted-by":"crossref","unstructured":"Stefanelli P, Gabriele B, Paola V, Tozzi AE, Fabio M, Rita C, Giorgio F, Alberto V, Carlo C, and The Pertussis Study Group (2017) Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization. Hum Vaccin Immunother 13(5):1073\u20131077","DOI":"10.1080\/21645515.2016.1276139"},{"key":"408_CR49","first-page":"1","volume":"54","author":"T Tiwari","year":"2005","unstructured":"Tiwari T, Murphy TV, Moran J (2005) Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 54:1\u201316","journal-title":"MMWR Recomm Rep"},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1016\/j.vaccine.2015.07.109","volume":"33","author":"C Vizzotti","year":"2015","unstructured":"Vizzotti C, Neyro S, Katz N, Ju\u00e1rez MV, Perez Carrega ME et al (2015) Maternal immunization in Argentina: a storyline from the prospective of a middle income country. Vaccine 33:6413\u20136419","journal-title":"Vaccine"},{"key":"408_CR51","doi-asserted-by":"publisher","first-page":"O825","DOI":"10.1111\/1469-0691.12671","volume":"20","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cui Z, Li Y, Hou T, Liu X, Xi Y et al (2014) High prevalence of erythromycin-resistant Bordetella pertussis in Xi\u2019an, China. Clin Microbiol Infect 20:O825\u2013O830","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"408_CR52","doi-asserted-by":"publisher","first-page":"pii: e00806-16","DOI":"10.1128\/JB.00806-16","volume":"199","author":"MR Weigand","year":"2017","unstructured":"Weigand MR, Peng Y, Loparev V, Batra D, Bowden KE, Burroughs M, Cassiday PK, Davis JK, Johnson T, Juieng P, Knipe K, Mathis MH, Pruitt AM, Rowe L, Sheth M, Tondella ML, Williams MM (2017) The history of Bordetella pertussis genome evolution includes structural rearrangement. J Bacteriol 199(8):pii: e00806-16","journal-title":"J Bacteriol"},{"issue":"3","key":"408_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/CMR.4.3.243","volume":"4","author":"BF Woolfrey","year":"1991","unstructured":"Woolfrey BF, Moody JA (1991) Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 4(3):243\u2013245","journal-title":"Clin Microbiol Rev"},{"key":"408_CR54","volume-title":"Pocket book for hospital care of children: guidelines for the management of common childhood illnesses","author":"World Health Organization (WHO)","year":"2013","unstructured":"World Health Organization (WHO) (2013) Pocket book for hospital care of children: guidelines for the management of common childhood illnesses, 2nd edn. World Health Organization, Geneva. http:\/\/apps.who.int\/iris\/bitstream\/10665\/81170\/1\/9789241548373_eng.pdf?ua=1","edition":"2"},{"key":"408_CR55","unstructured":"World Health Organization (WHO) (2018) Vaccine preventable diseases surveillance standards. Pertussis. Last updated September 5, 2018. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/standards\/en\/"},{"issue":"33","key":"408_CR56","doi-asserted-by":"publisher","first-page":"pii: 20881","DOI":"10.2807\/1560-7917.ES2014.19.33.20881","volume":"19","author":"A Zeddeman","year":"2014","unstructured":"Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, Hallander HO, Wirsing von Konig CH, Riffelman M, Storsaeter J, Vestrheim DF, Dalby T, Krogfelt KA, Fry NK, Barkoff AM, Mertsola J, He Q, Mooi F (2014) Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill 19(33):pii: 20881","journal-title":"Euro Surveill"},{"issue":"12","key":"408_CR57","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1099\/jmm.0.000860","volume":"67","author":"J Zintgraff","year":"2018","unstructured":"Zintgraff J, Irazu L, Lara CS, Rodriguez M, Santos M (2018) The classical Bordetella species and MALDI-TOF technology: a brief experience. J Med Microbiol 67(12):1737\u20131742","journal-title":"J Med Microbiol"}],"container-title":["Advances in Experimental Medicine and Biology","Pertussis Infection and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2019_408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T16:06:37Z","timestamp":1649952397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2019_408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030332488","9783030332495"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/5584_2019_408","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"19 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}